SRR1441224
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Male
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- DNA_REPAIR+0.124
- MITOTIC_SPINDLE+0.060
- KRAS_SIGNALING_DN+0.034
- MYC_TARGETS_V2-0.009
- UNFOLDED_PROTEIN_RESPONSE-0.020
- SPERMATOGENESIS-0.048
- WNT_BETA_CATENIN_SIGNALING-0.049
- PI3K_AKT_MTOR_SIGNALING-0.059
- MYC_TARGETS_V1-0.065
- PEROXISOME-0.069
Top 10 suppressed
- INTERFERON_ALPHA_RESPONSE-0.590
- TNFA_SIGNALING_VIA_NFKB-0.548
- INFLAMMATORY_RESPONSE-0.535
- INTERFERON_GAMMA_RESPONSE-0.520
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.509
- IL6_JAK_STAT3_SIGNALING-0.498
- ALLOGRAFT_REJECTION-0.483
- ANGIOGENESIS-0.476
- COAGULATION-0.468
- APOPTOSIS-0.460
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1359367 | GTEX | — | 0.988 |
| 2 | SRR1319672 | GTEX | — | 0.987 |
| 3 | SRR1419675 | GTEX | — | 0.987 |
| 4 | SRR1464305 | GTEX | — | 0.987 |
| 5 | SRR820468 | GTEX | — | 0.986 |
| 6 | SRR1477385 | GTEX | — | 0.986 |
| 7 | SRR1356204 | GTEX | — | 0.986 |
| 8 | SRR807657 | GTEX | — | 0.985 |
| 9 | SRR1490568 | GTEX | — | 0.985 |
| 10 | SRR1352415 | GTEX | — | 0.984 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 3 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| DNA_REPAIR | 0.124 | Idelalisib | — uncovered |
| MITOTIC_SPINDLE | 0.060 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.034 | Remibrutinib | — uncovered |